Preferred Label : elafibranor;
Origin ID : M000629003;
Currated CISMeF NLP mapping
- Related record
https://www.has-sante.fr/jcms/p_3576200/fr/iqirvo-elafibranor-cholangite-biliaire-primitive-cbp
2025
false
false
false
France
drug therapy, combination
evaluation of the transparency committee
cholangitis
elafibranor
Primary Biliary Cholangitis
---
https://www.ema.europa.eu/en/medicines/human/EPAR/iqirvo
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
administration, oral
elafibranor
elafibranor
orphan drug production
---
https://www.has-sante.fr/jcms/p_3588817/fr/iqirvo-elafibranor-cholangite-biliaire-primitive
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, oral
Primary Biliary Cholangitis
drug therapy, combination
ursodeoxycholic acid
adult
elafibranor
evaluation of the transparency committee
elafibranor
---
